Logo
  • Home
  • About Us
  • News & Events
  • EVI
  • Scanner Tool
  • Pharmaceutical Companies
  • Self Service Portal
  • Knowledge DB
  • Careers
  • Contact
×
  • Home
  • About Us
  • News & Events
  • EVI
  • Scanner Tool
  • Pharmaceutical Companies
  • Self Service Portal
  • Knowledge DB
  • Careers
  • Contact
    EMVO’s Mission
    The risk of falsified medicines is growing on a global scale. As a result, the European Union has stipulated a catalogue of measures in Directive 2011/62/EU to prevent falsified medicines from enter...
    Organisation and Structure
    The European Medicines Verification Organisation (EMVO) is a Belgian non-profit organisation representing stakeholders united in securing the legal supply chain from falsified medicines. Its founding ...
    The EMVS and NMVOs
    In order to counter the threat of falsified medicines entering the legal supply chain, the European Parliament and Council have released a Directive on Falsified Medicines (2011/62/EU) (amending Dir...
    Newsletter
    EMVO is now making available a newsletter on a regular basis to provide an update on our activities....
    OBP Portal
    To facilitate the On-boarding Process to the EU Hub, EMVO provides you a user-friendly web-based “EMVO On-boarding Partner Portal (OBP Portal)” that will guide you step by step through the process...
    Connected Companies
    This list reflects the OBPs and MAHs connected in PRD. ...
Q&A Document on EU Hub Certificates Renewal & Alert endpoints_Version 4
Read More
It’s the EMVS’s Birthday! The European Medicines Verification System’s third anniversary
Read More
Letter of Announcement: EU Hub Release 1.9—Initial deployment dates for ITE, IQE and PRD
Read More
Letter of Announcement: Planned maintenance to the OBP Portal
Read More
Letter of Announcement: Archiving the backlog of A7 alerts (remaining in the retry queue from 2020)
Read More
Letter of Announcement: Clarifying the uploading requirements for packs intended for supply in Northern Ireland into the EMVS
Read More
Letter of Announcement: Update—Clearing the backlog of A7 alerts
Read More
Letter of Announcement: Happy birthday EMVS! The European Medicines Verification System’s second anniversary
Read More
Letter of Announcement: Keep informed about the latest EMVS incidents—Subscribe to EVI
Read More
Letter of Announcement: EMVO’s communication regarding the impact of Brexit and the Northern Ireland Protocol in the EMVS following the EU Commission’s Notice
Read More
Letter of Announcement: EMVO support and Helpdesk—Holiday season availability
Read More
Letter of Announcement: EU Hub Release 1.8 deployment confirmation
Read More
Brexit: Draft Q&A Article
Read More
Letter of Announcement: Renewal of the EU Hub’s security certificate
Read More
Letter of Announcement: Release 1.8–Change to “A99 – Possible counterfeit” code in the header
Read More
Letter of Announcement: EU Hub Release 1.8 deployment date for PRD
Read More
Letter of Announcement: The impact of Brexit and the Northern Ireland Protocol in the EMVS
Read More
Letter of Announcement: EU Hub Release 1.8—Confirmation of deployment to IQE
Read More
Letter of Announcement: Static IP addresses for the EU Hub – PRD deadline
Read More
Letter of Announcement: EU Hub Release 1.8—Confirmation of deployment to ITE
Read More
Letter of Announcement: EU Hub Release 1.8—Deployment dates for ITE, IQE and PRD, and the deadline to update your IP addresses
Read More
Letter of Announcement: Improving EMVO’s communication channels
Read More
Letter of Announcement: Static IP addresses for the EU Hub
Read More
Letter of Announcement: The Alert Management System (AMS) project
Read More
Letter of Announcement: Reminder — Support for the 2016 schema will end in Q4 2020
Read More
Letter of Announcement: EMVS Alerts & Notifications document
Read More
Letter of Announcement: EU Hub Release 1.7.01 – complete
Read More
Letter of Announcement: Consequences of Data Withdrawal & Batch recall
Read More
Letter of Announcement: EMVO’s FMD Workshop in May
Read More
Letter of Announcement: COVID-19 Measures Update
Read More
Letter of Announcement: EU Hub Release 1.7 ITE & IQE confirmation
Read More
Letter of Announcement: EU Hub Release 1.7 ITE, IQE & PRD deployment
Read More
Letter of Announcement: COVID-19 Measures
Read More
Questions and Answers V17.0 – New Release
Read More
Letter of Announcement: Master Data Maintenance – Versioning and Retrospective Upload
Read More
Letter of Announcement: Updated Fee Models
Read More
Letter of Announcement: EU Hub release 1.7
Read More
The European Medicines Verification System (EMVS) celebrates 1 year of successful operation across Europe
Read More
New Office Address and Telephone Numbers
Read More
Letter of Announcement: EMVO Helpdesk and OBP Support
Read More
    home: News & Events
    ALL
    NEWS
    EVENTS
    print
    email
    share
    Brussels

    Latest news from EMVO

    News, Events, Documents…

    "Follow the European Medicines Verification Organisation to get the latest news. Join our network!"
    news
    published on: 16.12.2022
    EMVS Community Newsletter- 2022 Holiday Bulletin

    In this special holiday edition, we want to wish you all a great holiday season by showcasi...

    news
    published on: 28.10.2022
    EMVS Community Newsletter October 2022

    Welcome to this new edition of the EMVS (European Medicines Verification System) Community Newsletter! This edition a...

    news
    published on: 17.08.2022
    EMVS Community Newsletter Summer Bulletin 2022

    Welcome to this special summer edition of the EMVS (European Medicines Verification System) Community Newsletter! For...

    news
    published on: 14.06.2022
    EMVS Community Newsletter June 2022

    Welcome to this new edition of the EMVS (European Medicines Verification System) Comm...

    news
    published on: 18.05.2022
    Q&A Document on EU Hub Certificates Renewal & Alert endpoints_Version 4

    This document sets out the main questions raised during the Q&A sessions regarding the renewal of the EU Hub publ...

    news
    published on: 10.05.2022
    Webcast Series Second Episode – OBP Data Upload Quality

    EMVO is excited to share the second episode of the EMVO Webcast series! This episode focuses on the q...

    +
    • Home
    • About Us
    • News & Events
    • Pharmaceutical Companies
    • Knowledge DB
    • Careers
    • Contact
    • Cookie Policy
    • Terms of Use
    • Privacy Policy

    European Medicines
    Verification Organisation

    CONTACT:
    +32 2 657 00 08
    helpdesk@emvo-medicines.eu
    SOCIAL:
    #EMVO #EMVS
    #FMD #FightFakes

    ©2023 • All Rights Reserved to EMVO asbl • Rue du Commerce 123 - 1000 Brussels, Belgium • VAT nr: BE 0638.801.022

    Tweets by emvo_official
    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
    Cookie settingsACCEPT
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
    Necessary
    Always Enabled

    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

    Non Necessary

    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

    Save & Accept